These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 10070137)

  • 1. Endothelin-1 and CYP450 arachidonate metabolites interact to promote tissue injury in DOCA-salt hypertension.
    Oyekan AO; McAward K; Conetta J; Rosenfeld L; McGiff JC
    Am J Physiol; 1999 Mar; 276(3):R766-75. PubMed ID: 10070137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heme arginate therapy enhanced adiponectin and atrial natriuretic peptide, but abated endothelin-1 with attenuation of kidney histopathological lesions in mineralocorticoid-induced hypertension.
    Ndisang JF; Jadhav A
    J Pharmacol Exp Ther; 2010 Jul; 334(1):87-98. PubMed ID: 20392817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats.
    Matsumura Y; Hashimoto N; Taira S; Kuro T; Kitano R; Ohkita M; Opgenorth TJ; Takaoka M
    Hypertension; 1999 Feb; 33(2):759-65. PubMed ID: 10024341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic endopeptidase inhibition in DOCA-salt hypertension: mechanism of cardiovascular protection.
    Newaz MA; Yousefipour Z; Hercule H; Truong L; Oyekan A
    Clin Exp Hypertens; 2003 Aug; 25(6):335-47. PubMed ID: 12940471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of alpha-lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats.
    Takaoka M; Kobayashi Y; Yuba M; Ohkita M; Matsumura Y
    Eur J Pharmacol; 2001 Jul; 424(2):121-9. PubMed ID: 11476758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pergolide on blood pressure and tissue injury in DOCA-salt hypertension.
    Newaz MA; Yousefipour Z; Oyekan A
    Blood Press; 2002; 11(2):110-5. PubMed ID: 12035871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of Ras GTPase/MAP kinase and cytochrome P450 metabolites to deoxycorticosterone-salt-induced hypertension.
    Muthalif MM; Benter IF; Khandekar Z; Gaber L; Estes A; Malik S; Parmentier JH; Manne V; Malik KU
    Hypertension; 2000 Jan; 35(1 Pt 2):457-63. PubMed ID: 10642341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of cardiac dysfunction by selective ET-A receptor antagonism.
    Allan A; Fenning A; Levick S; Hoey A; Brown L
    Br J Pharmacol; 2005 Nov; 146(6):846-53. PubMed ID: 16151437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ETA receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats.
    Allcock GH; Venema RC; Pollock DM
    Am J Physiol; 1998 Jul; 275(1):R245-52. PubMed ID: 9688985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased renal medullary endothelin-1 synthesis in prehypertensive DOCA- and salt-treated rats.
    Hsieh TJ; Lin SR; Lee YJ; Shin SJ; Lai YH; Hsu CH; Tsai JH
    Am J Physiol Renal Physiol; 2000 Jul; 279(1):F112-21. PubMed ID: 10894793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exaggerated vascular and renal pathology in endothelin-B receptor-deficient rats with deoxycorticosterone acetate-salt hypertension.
    Matsumura Y; Kuro T; Kobayashi Y; Konishi F; Takaoka M; Wessale JL; Opgenorth TJ; Gariepy CE; Yanagisawa M
    Circulation; 2000 Nov; 102(22):2765-73. PubMed ID: 11094045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial fibrosis in DOCA-salt hypertensive rats: effect of endothelin ET(A) receptor antagonism.
    Ammarguellat F; Larouche I; Schiffrin EL
    Circulation; 2001 Jan; 103(2):319-24. PubMed ID: 11208696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced expression of the endothelin-1 gene in blood vessels of DOCA-salt hypertensive rats: correlation with vascular structure.
    Schiffrin EL; Larivière R; Li JS; Sventek P
    J Vasc Res; 1996; 33(3):235-48. PubMed ID: 8924521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heme-arginate suppresses phospholipase C and oxidative stress in the mesenteric arterioles of mineralcorticoid-induced hypertensive rats.
    Ndisang JF; Jadhav A
    Hypertens Res; 2010 Apr; 33(4):338-47. PubMed ID: 20203687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
    Li JS; Turgeon A; Schiffrin EL
    Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnesium supplementation and deoxycorticosterone acetate--salt hypertension: effect on arterial mechanical properties and on activity of endothelin-1.
    Berthon N; Laurant P; Hayoz D; Fellmann D; Brunner HR; Berthelot A
    Can J Physiol Pharmacol; 2002 Jun; 80(6):553-61. PubMed ID: 12117304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin receptor blockade ameliorates renal injury by inhibition of RhoA/Rho-kinase signalling in deoxycorticosterone acetate-salt hypertensive rats.
    Lee TM; Chung TH; Lin SZ; Chang NC
    J Hypertens; 2014 Apr; 32(4):795-805. PubMed ID: 24463935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF-alpha inhibition reduces renal injury in DOCA-salt hypertensive rats.
    Elmarakby AA; Quigley JE; Imig JD; Pollock JS; Pollock DM
    Am J Physiol Regul Integr Comp Physiol; 2008 Jan; 294(1):R76-83. PubMed ID: 17989143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin-1 gene expression and vascular hypertrophy in DOCA-salt hypertension compared to spontaneously hypertensive rats.
    Schiffrin EL; Lariviere R; Li JS; Sventek P; Touyz RM
    Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S188-90. PubMed ID: 9072349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2,3',4,5'-Tetramethoxystilbene prevents deoxycorticosterone-salt-induced hypertension: contribution of cytochrome P-450 1B1.
    Sahan-Firat S; Jennings BL; Yaghini FA; Song CY; Estes AM; Fang XR; Farjana N; Khan AI; Malik KU
    Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1891-901. PubMed ID: 20852048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.